Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine

Journal of Virological Methods

Volumn 182, Issue 1-2, 2012, Pages 43-49

  Cheng, Li Wei ^a   Huang, Sheng Wen ^a   Huang, Li Min ^b   Chang, Luan Yin ^b   Shao, Pei Lan ^b   Kiang, David ^c   Wang, Jen Ren ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Food and Drug Laboratory Branch   (United States)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Antibody response; Immunization; Influenza virus; Microneutralization test; Neutralizing antibody

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENETICS; INFECTION PREVENTION; INFLUENZA B; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEROCONVERSION; VACCINE PRODUCTION; VIRUS NEUTRALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION TESTS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ORTHOMYXOVIRIDAE;

EID: 84862783922     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.03.004     Document Type: Article

References (30)

1. Ansaldi F., Bacilieri S., Banfi F., Durando P., Sticchi L., Icardi G., Gasparini R. Neutralizing and hemagglutination-inhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted viruses. Clin. Vacc. Immunol. 2006, 13:162-164.
2. Beare A.S., Webster R.G. Replication of avian influenza viruses in humans. Arch. Virol. 1991, 119:37-42.
3. Benne C.A., Harmsen M., De Jong J.C., Kraaijeveld C.A. Neutralization enzyme immunoassay for influenza virus. J. Clin. Microbiol. 1994, 32:987-990.
4. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
5. de Bruijn I.A., Remarque E.J., Beyer W.E., le Cessie S., Masurel N., Ligthart G.J. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 1997, 15:1323-1329.
6. Doherty P.C., Turner S.J., Webby R.G., Thomas P.G. Influenza and the challenge for immunology. Nat. Immunol. 2006, 7:449-455.
7. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
8. Global Influenza Programme, WHO, 2002. WHO Manual on Animal Influenza Diagnosis and Surveillance.
9. Gross P.A., Denning C.R., Gaerlan P.F., Bonelli J., Bernius M., Dran S., Monk G., Vassallo M., Quinnan G.V., Levandowski R., Cataruozolo P.E., Wallenstein S. Annual influenza vaccination: immune response in patients over 10 years. Vaccine 1996, 14:1280-1284.
10. Harmon M.W., Rota P.A., Walls H.H., Kendal A.P. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J. Clin. Microbiol. 1988, 26:333-337.
11. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227:493-499.
12. Keitel W.A., Cate T.R., Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am. J. Epidemiol. 1988, 127:353-364.
13. Keitel W.A., Cate T.R., Couch R.B., Huggins L.L., Hess K.R. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997, 15:1114-1122.
14. Masurel N., Laufer J. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. J. Hyg. (Lond.) 1984, 92:263-276.
15. Nabeshima S., Kashiwagi K., Murata M., Kanamoto Y., Furusyo N., Hayashi J. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. J. Med. Virol. 2007, 79:320-325.
16. Naffakh N., van der Werf S. April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes Infect. 2009, 11:725-728.
17. Nelson M.I., Holmes E.C. The evolution of epidemic influenza. Nat. Rev. Genet. 2007, 8:196-205.
18. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453:615-619.
19. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
20. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N. Engl. J. Med. 2001, 344:889-896.
21. Remarque E.J., de Bruijn I.A., Boersma W.J., Masurel N., Ligthart G.J. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J. Med. Virol. 1998, 55:82-87.
22. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999, 37:937-943.
23. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., Gust I.D., Hampson A.W., Hay A.J., Hurt A.C., de Jong J.C., Kelso A., Klimov A.I., Kageyama T., Komadina N., Lapedes A.S., Lin Y.P., Mosterin A., Obuchi M., Odagiri T., Osterhaus A.D., Rimmelzwaan G.F., Shaw M.W., Skepner E., Stohr K., Tashiro M., Fouchier R.A., Smith D.J. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008, 320:340-346.
24. Shinde V., Bridges C.B., Uyeki T.M., Shu B., Balish A., Xu X., Lindstrom S., Gubareva L.V., Deyde V., Garten R.J., Harris M., Gerber S., Vagasky S., Smith F., Pascoe N., Martin K., Dufficy D., Ritger K., Conover C., Quinlisk P., Klimov A., Bresee J.S., Finelli L. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N. Engl. J. Med. 2009, 360:2616-2625.
25. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
26. Stephenson I., Das R.G., Wood J.M., Katz J.M. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 2007, 25:4056-4063.
27. Stephenson I., Wood J.M., Nicholson K.G., Zambon M.C. Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J. Med. Virol. 2003, 70:391-398.
28. Subbarao K., Murphy B.R., Fauci A.S. Development of effective vaccines against pandemic influenza. Immunity 2006, 24:5-9.
29. WHO, 2003. World Health Organization factsheet 211: influenza.
30. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 1990, 8:737-771.